Drug profile · INN
epirubicin hydrochloride
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride (EPIRUBICIN HYDROCHLORIDE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — epirubicin hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
epirubicin hydrochloride (EPIRUBICIN HYDROCHLORIDE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is epirubicin hydrochloride?
epirubicin hydrochloride (EPIRUBICIN HYDROCHLORIDE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for epirubicin hydrochloride?
EPIRUBICIN HYDROCHLORIDE is a marketed brand name for epirubicin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of epirubicin hydrochloride?
epirubicin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.